NanoBioPharmaceut...
Follow
Find
2.4K views | +0 today
NanoBioPharmaceuticals
Newsradar about nanotechnology enabled biopharmaceuticals
Curated by Luís Bastos
Your new post is loading...
Your new post is loading...
Scooped by Luís Bastos
Scoop.it!

OICR and MaRS Innovation announce funding to develop Cellax ...

OICR and MaRS Innovation announce funding to develop Cellax ... | NanoBioPharmaceuticals | Scoop.it

The Ontario Institute for Cancer Research (OICR) and MaRS Innovation (MI) today announced $1.5 million in funding from OICR over three years to further develop Cellax™, a nanoparticle drug that could offer an alternative to chemotherapy with fewer side effects.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Video abstract Nanocarriers for transdermal drug delivery

Video abstract of review paper "Nanocarriers for transdermal drug delivery" published in the open access journal Research and Reports in Transdermal Drug Delivery by Jose Juan Escobar-Chavez, Roberto Diaz Torres, Isabel Marlen Rodriguez-Cruz, et al.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

The production site of the Russian pharmaceutical company NovaMedica will be chosen in the 1st quarter of 2013

The production site of the Russian pharmaceutical company NovaMedica will be chosen in the 1st quarter of 2013 | NanoBioPharmaceuticals | Scoop.it

NovaMedica is a new pharmaceutical company, established as an integral part of the $760 million collaboration between the Russian high-technology investment fund RUSNANO and the American healthcare venture fund Domain Associates LLC.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Cardioid Simulation of Drug Interaction

In the simulation with the drug, a reentrant circulation pattern develops, inhibiting repolarization of the cells and thus preventing the heart from beating normally.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Robot pill

Robot pill | NanoBioPharmaceuticals | Scoop.it

A tiny robotic pill that will deliver therapies to hard-to-reach places inside the body is being developed by researchers.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

2012 ASHP Foundation Literature Awards Announced - Pharmacy Practice News

2012 ASHP Foundation Literature Awards Announced - Pharmacy Practice News | NanoBioPharmaceuticals | Scoop.it

The five winners of the American Society of Health-System Pharmacists (ASHP) Research and Education Foundation’s 2012 Literature Awards will be recognized at the Midyear Clinical Meeting in Las Vegas. To honor their extraordinary contributions, Pharmacy Practice News spoke to each of the honorees.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Nanomedicine to improve drug delivery outcomes Joshi M, Tiwari G, Tiwari R, Srivastava B - Chron Young Sci

Nanomedicine to improve drug delivery outcomes Joshi M, Tiwari G, Tiwari R, Srivastava B - Chron Young Sci | NanoBioPharmaceuticals | Scoop.it

The early genesis of the concept of nanomedicine sprang from the visionary idea that tiny nanorobots and related machines could be designed, manufactured, and introduced into the human body to perform cellular repairs at the molecular level. Nanomedicine today has branched out in hundreds of different directions, each of them embodying the key insight that the ability to structure materials and devices at the molecular scale can bring enormous immediate benefits in the research and practice of medicine. The integration of nanotechnology with biology and medicine has given birth to a new field of science called "Nanomedicine".

more...
No comment yet.
Rescooped by Luís Bastos from Nano in Regenerative Medicine & Tissue Engineering
Scoop.it!

Cambridge Univ. Spin-Off Creates Drug Testing Stem Cells ...

Cambridge Univ. Spin-Off Creates Drug Testing Stem Cells ... | NanoBioPharmaceuticals | Scoop.it

A spin-off company from Cambridge University in the U.K. is commercializing a technology to convert adult stem cells into human liver cells suitable for drug testing. The technology, say its developers from Cambridge’s Anne McLaren Laboratory for Regenerative Medicine, can also test for a number of inherited liver diseases and has the potential to accelerate development of new therapies for these conditions.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Preparation of Biocompatible Nanoparticles of Chitosan with ...

Preparation of Biocompatible Nanoparticles of Chitosan with ... | NanoBioPharmaceuticals | Scoop.it

The development of more sophisticated and biocompatible DDSs is extremely important for further improvents in the efficiency of health care treatments and represents an ever-evolving subject in the field of biomedical materials science. In this regard, particulated materials have attracted an enormous attention as DDSs not only for its great potential for the controlled release of drugs, but also because of the rapid development of synthetic methods for controlling morphology and particle size from the micro to the nanoscale. Within this context, several technologies have matured in the last decade for the production of micro/nanoparticles to serve as carriers for the delivery of drugs or biomolecules. These methods have been essentially boosted by the pharmaceutical industry in the search for enhanced target selectivity and cell penetration capabilities. As a consequence of that effort, a myriad of nanometeric carriers with different morphologies (nanospheres, nanofibers, nanocapsules, nanomicelles, nanoliposomes, nanobelts, and so on) are now available to the researcher.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

NanoMedRev Blog: Nanobioethics and Nanoethics

NanoMedRev Blog: Nanobioethics and Nanoethics | NanoBioPharmaceuticals | Scoop.it
All debates on Nanobioethics and Nanoethics must have the level of excellence (and not just part of them).
more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Nanoparticle delivery system delivers more drugs, more precisely ...

Nanoparticle delivery system delivers more drugs, more precisely ... | NanoBioPharmaceuticals | Scoop.it

The delivery system consists of specially designed nanoparticles that home in on tumor cells while carrying the anti-cancer drug paclitaxel. The same delivery system successfully carried a dye that lights up on imaging studies, making it potentially useful for diagnostic purposes. The findings are published in the journal Nanomedicine as “Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer.”

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

U.Va. Cancer Initiative Invests $300000 in Public-Private Research Partnerships - University of Virginia

U.Va. Cancer Initiative Invests $300000 in Public-Private Research Partnerships - University of Virginia | NanoBioPharmaceuticals | Scoop.it

U.Va. oncologist Dr. Benjamin Purow is partnering with Reston-based nanopharmaceutical company Parabon NanoLabs Inc. to produce and test nano-pharmaceutical P25+Gd as a “plug-and-play” drug for simultaneous treatment and real-time monitoring of glioblastoma multiforme, or brain cancer.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Scopus preview - Scopus - Document details

RNA interference (RNAi) technology represents a fundamentally new category of treatments for human disease by addressing targets that are traditionally considered undruggable with existing medicines. The major challenge for RNAi-based therapy is the delivery system that meets human therapeutic needs. Therefore, engineering vectors with good delivery efficiency and safety profile is an intense area of research. Lipid-based nanoparticles for RNAi have yielded successful advances in vivo and to an extent in clinical trials. In this review, we discuss the barriers in developing lipid-based nanoparticles for in vivo RNAi and different strategies to overcome them. Rational designs that address safety concerns and ensure effective delivery will aid the translation of engineered lipid-based nanoparticles toward the clinic in the foreseeable future. Copyright © 2011 by Annual Reviews. All rights reserved.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

DUVI. Diario da Universidade de Vigo - A Universidade e a spin-off Nanoimmunotech participan na creación da primeira vacina contra a cistite

DUVI. Diario da Universidade de Vigo - A Universidade e a spin-off Nanoimmunotech participan na creación da primeira vacina contra a cistite | NanoBioPharmaceuticals | Scoop.it

En colaboración coa USC e coas empresas galegas CZ Veterinaria-Biofabri e Nanogap.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Phase I IDMC confirms good safety of NBTXR3 in the first group of patients with advanced STS | nanobiotix

Nanobiotix (Euronext: NANO / ISIN: FR0011341205), announced today that the Independent Data Monitoring Committee (IDMC) has reviewed the data of the first 6 patients treated in the phase I Study with the lead product NBTXR3 for the treatment of advanced Soft Tissue Sarcoma of the extremity. Based on the review of the safety data, the IDMC has unanimously recommended continuing the enrollment in the study according to the protocol. This trial is realized in the Institut Gustave Roussy, France.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Lung Cancer (NSCLC), drug administration and nanotechnology ...

Lung Cancer (NSCLC), drug administration and nanotechnology ... | NanoBioPharmaceuticals | Scoop.it

Since lung cancer is the most leading cause of death in both man and women, and have gained lots of attention I am interested in elaborating on NSCLC and explore the potential use of nanotechnology in this matter.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

First Demonstration of Cancer Drug Delivery in Humans Using ...

A completely new way of delivering anti-cancer drugs to tumours, using 'minicells' derived from bacteria, has been tested for the first time in humans and found to be safe, well-tolerated and even induced stable disease in patients with advanced, incurable cancers with no treatment options remaining.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Taiwan, Japan ink pharmaceutical collaboration pact | The China ...

Taiwan, Japan ink pharmaceutical collaboration pact | The China ... | NanoBioPharmaceuticals | Scoop.it

Taiwan’s Orient Europharma Co. Ltd. and Japan-based NanoCarrier Co. Ltd. concluded a licensing agreement Nov. 7 in Taipei City, paving the way for closer cooperation in pharmaceutical R&D between the two firms.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Headline Story | equities.com

Research findings on Cancer Research are discussed in a new report. According to news reporting originating from Tehran, Iran, by NewsRx correspondents, research stated, "The main aim of nanomedicine is to revolutionize the health care system and find effective approaches to fighting fatal diseases. Therapeutic beams, which are employed in radiation therapy, do not discriminate between normal and cancerous cells and must rely on targeting the radiation beams to specific cells."

more...
No comment yet.
Rescooped by Luís Bastos from NanoBiomedical Diagnostics
Scoop.it!

New research award drives development of nanoscale diagnostics ...

New research award drives development of nanoscale diagnostics ... | NanoBioPharmaceuticals | Scoop.it

Hao Yan, a researcher at Arizona State University’s Biodesign Institute, is working in one such domain. Known as theranostics, (a contraction of ‘therapy’ and ‘diagnostics’), the research represents a fresh approach to the diagnosis and treatment of disease, relying on nano-scale agents fabricated to carry out a range of functions in the body.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Biology Biomedical Engineering Biotechnology Cell Biology Jobs ...

Biology Biomedical Engineering Biotechnology Cell Biology Jobs ... | NanoBioPharmaceuticals | Scoop.it

The research topics of our laboratory include nanosystems for anticancer drug delivery, intracellular protein and peptide drug delivery, multifunctional polymeric gene delivery systems, injectable biodegradable hydrogels, and functional biodegradable polymers.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Fars News Agency :: Iranian Companies Attend Innovations Expo in Moscow

Fars News Agency :: Iranian Companies Attend Innovations Expo in Moscow | NanoBioPharmaceuticals | Scoop.it

The International Open Innovations Expo 2012 started work in Moscow's Expo Center with Iranian companies in attendance.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

UQ working to produce cheap vaccines quickly - UQ News Online - The University of Queensland

UQ working to produce cheap vaccines quickly - UQ News Online - The University of Queensland | NanoBioPharmaceuticals | Scoop.it

Immunising people with vaccines that are quick and inexpensive to produce is the answer to preventing large-scale spread of infectious disease, Professor Anton Middelberg from UQ's Australian Institute for Bioengineering and Nanotechnology says.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

VNT Paclitaxel Nanocarrier-Based Drug Coated Balloon Technology Performs ... - AZoNano.com

Vascular Nanotransfer Technologies (“VNT”), an emerging medical technology company, announced today that large animal model in vivo tests of its paclitaxel nanocarrier-based Drug Coated Balloon (“DCB”) achieved tissue levels comparable to devices with proven clinical efficacy.

more...
No comment yet.
Scooped by Luís Bastos
Scoop.it!

Effect of supercritical fluid density on nanoencapsulated drug particle size using the supercritical antisolvent method

The reported work demonstrates and discusses the effect of supercritical fluid density (pressure and temperature of supercritical fluid carbon dioxide) on particle size and distribution using the supercritical antisolvent (SAS) method in the purpose of drug encapsulation. In this study, paracetamol was encapsulated inside L-polylactic acid, a semicrystalline polymer, with different process parameters, including pressure and temperature, using the SAS process. The morphology and particle size of the prepared nanoparticles were determined by scanning electron microscopy and transmission electron microscopy. The results revealed that increasing temperature enhanced mean particle size due to the plasticizing effect. Furthermore, increasing pressure enhanced molecular interaction and solubility; thus, particle size was reduced. Transmission electron microscopy images defined the internal structure of nanoparticles. Thermal characteristics of nanoparticles were also investigated via differential scanning calorimetry. Furthermore, X-ray diffraction pattern revealed the changes in crystallinity structure during the SAS process. In vitro drug release analysis determined the sustained release of paracetamol in over 4 weeks.

more...
No comment yet.